UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TGFβ promotes conversion of CD16⁺ peripheral blood NK cells into CD16⁻ NK cells with similarities to decidual NK cells

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (9), p.3378-3383

2007

Volltextzugriff (PDF)

Inhibition of integrin αVβ6 changes fibril thickness of stromal collagen in experimental carcinomas

Cell communication and signaling, 2018-07, Vol.16 (1), p.36-36, Article 36

2018

Volltextzugriff (PDF)

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Nature medicine, 2018-02, Vol.24 (2), p.203-212

2018

Volltextzugriff (PDF)

Disulfide Bond-Mediated Dimerization of HLA-G on the Cell Surface

Proceedings of the National Academy of Sciences - PNAS, 2002-12, Vol.99 (25), p.16180-16185

2002

Volltextzugriff (PDF)

CD1d and Invariant NKT Cells at the Human Maternal-Fetal Interface

Proceedings of the National Academy of Sciences - PNAS, 2002-10, Vol.99 (21), p.13741-13746

2002

Volltextzugriff (PDF)

Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders

Translational research : the journal of laboratory and clinical medicine, 2022-11, Vol.249, p.49-73

2022

Volltextzugriff (PDF)

Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential

The Journal of experimental medicine, 2003-10, Vol.198 (8), p.1201-1212

2003

Volltextzugriff (PDF)

Evaluation of Tyro3 Expression, Gas6-Mediated Akt Phosphorylation, and the Impact of Anti-Tyro3 Antibodies in Melanoma Cell Lines

Biochemistry (Easton), 2013-05, Vol.52 (18), p.3102-3118

2013

Volltextzugriff (PDF)

Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer

JCI insight, 2019-11, Vol.4 (21)

2019

Volltextzugriff (PDF)

Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-α and interleukin-1β in first trimester human decidual cells : Implications for preeclampsia

The American journal of pathology, 2006-02, Vol.168 (2), p.445-452

2006

Volltextzugriff (PDF)

Viral evasion of natural killer cells

Nature immunology, 2002-11, Vol.3 (11), p.1006-1012

2002

Volltextzugriff (PDF)

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models

Life science alliance, 2022-11, Vol.5 (11), p.e202201481

2022

Volltextzugriff (PDF)

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

The Journal of experimental medicine, 2000-03, Vol.191 (6), p.961-976

2000

Volltextzugriff (PDF)

Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism

Cancer research (Chicago, Ill.), 2008-01, Vol.68 (2), p.561-570

2008

Volltextzugriff (PDF)

Inflammatory Cytokine and Thrombin Regulation of Interleukin-8 and Intercellular Adhesion Molecule-1 Expression in First Trimester Human Decidua

The journal of clinical endocrinology and metabolism, 2005-08, Vol.90 (8), p.4710-4715

2005

Volltextzugriff (PDF)

Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines

Cancer research (Chicago, Ill.), 1999-11, Vol.59 (21), p.5615-5624

1999

Volltextzugriff (PDF)

Abstract 4591: Specific elimination of invasive and multidrug-resistant cancer cells by an antibody-drug conjugate targeting AXL

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4591-4591

2017

Volltextzugriff (PDF)

Abstract 832: An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.832-832

2018

Volltextzugriff (PDF)

Abstract IA004: Preclinical development of DuoBody®-CD3xB7H4, a novel CD3 bispecific antibody for the treatment of solid cancers

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.IA004-IA004

2023

Volltextzugriff (PDF)

Inhibition of integrin [alpha]V[beta]6 changes fibril thickness of stromal collagen in experimental carcinomas

Cell communication and signaling, 2018-07, Vol.16 (1)

2018

Volltextzugriff (PDF)

Inhibition of integrin alpha(V)beta(6) changes fibril thickness of stromal collagen in experimental carcinomas

Cell communication and signaling, 2018, Vol.16

2018

Volltextzugriff (PDF)

Inhibition of integrin α V β 6 changes fibril thickness of stromal collagen in experimental carcinomas

Cell communication and signaling, 2018-07, Vol.16 (1), p.36

2018

Volltextzugriff (PDF)

Antibody-Mediated Blockade of Integrin αvβ6Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β-Regulated Mechanism

Cancer research (Chicago, Ill.), 2008-01, Vol.68 (2), p.561-570

2008

Volltextzugriff (PDF)

TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (9), p.3378-3383

2007

Volltextzugriff (PDF)

TGF beta promotes conversion of CD16 super(+) peripheral blood NK cells into CD16 super(-) NK cells with similarities to decidual NK cells

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (9), p.3378-3383

2007

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

TGFβ promotes conversion of CD16⁺ peripheral blood NK cells into CD16⁻ NK cells with similarities to decidual NK cells

Inhibition of integrin αVβ6 changes fibril thickness of stromal collagen in experimental carcinomas

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Disulfide Bond-Mediated Dimerization of HLA-G on the Cell Surface

CD1d and Invariant NKT Cells at the Human Maternal-Fetal Interface

Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders

Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential

Evaluation of Tyro3 Expression, Gas6-Mediated Akt Phosphorylation, and the Impact of Anti-Tyro3 Antibodies in Melanoma Cell Lines

Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer

Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-α and interleukin-1β in first trimester human decidual cells : Implications for preeclampsia

Viral evasion of natural killer cells

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism

Inflammatory Cytokine and Thrombin Regulation of Interleukin-8 and Intercellular Adhesion Molecule-1 Expression in First Trimester Human Decidua

Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines

Abstract 4591: Specific elimination of invasive and multidrug-resistant cancer cells by an antibody-drug conjugate targeting AXL

Abstract 832: An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

Abstract IA004: Preclinical development of DuoBody®-CD3xB7H4, a novel CD3 bispecific antibody for the treatment of solid cancers

Inhibition of integrin [alpha]V[beta]6 changes fibril thickness of stromal collagen in experimental carcinomas

Inhibition of integrin alpha(V)beta(6) changes fibril thickness of stromal collagen in experimental carcinomas

Inhibition of integrin α V β 6 changes fibril thickness of stromal collagen in experimental carcinomas

Antibody-Mediated Blockade of Integrin αvβ6Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β-Regulated Mechanism

TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells

TGF beta promotes conversion of CD16 super(+) peripheral blood NK cells into CD16 super(-) NK cells with similarities to decidual NK cells

Suchergebnisse filtern